Stocktoria

Cresco Labs Inc. CRLBF

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2018-12-03 · LEI

Cresco Labs Inc. statistics & valuation

Market cap$531.2M
P / S0.8×
P / B1.6×
P / FCF14.1×
Net margin-20.6%
Return on equity-39.8%
FCF margin5.8%
Net debt$359.2M
Net debt / EBITDA17.3×
Enterprise value USD$890.4M
EV / EBITDA43×
Earnings yield EBIT/EV-3.1%
Return on capital-2.6%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-22.80% -10.30% -20.60% 202320242025
Gross margin (%)
47.00% 50.30% 49.50% 202320242025
Operating margin (%)
-11.40% 14.80% -4.30% 202320242025
Return on equity (%)
-34.70% -15.70% -39.80% 202320242025
Shares outstanding
323.8M 345.5M 355.0M 202320242025
Net debt ($)
$394.3M $323.2M $359.2M 202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-12.90% -5.50% -11.30% 202320242025
Free cash flow margin (%)
0.40% 15.60% 5.80% 202320242025
Debt / equity (×)
0.98× 0.97× 1.23× 202320242025
EPS ($)
-$0.54 -$0.22 -$0.38 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin49.5%50.3%47.0%
Operating margin-4.3%14.8%-11.4%
Net margin-20.6%-10.3%-22.8%
FCF margin5.8%15.6%0.4%
Return on assets-11.3%-5.5%-12.9%
Return on equity-39.8%-15.7%-34.7%
Debt / equity1.23×0.97×0.98×
Current ratio2.593.121.39

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.